Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist (Q40996903)
Jump to navigation
Jump to search
scientific article published on November 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist |
scientific article published on November 1998 |
Statements
1 reference
Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist (English)
1 reference
Hale JJ
1 reference
Mills SG
1 reference
MacCoss M
1 reference
Finke PE
1 reference
Cascieri MA
1 reference
Sadowski S
1 reference
Ber E
1 reference
Chicchi GG
1 reference
Kurtz M
1 reference
Metzger J
1 reference
Eiermann G
1 reference
Tsou NN
1 reference
Tattersall FD
1 reference
Rupniak NM
1 reference
Williams AR
1 reference
Rycroft W
1 reference
Hargreaves R
1 reference
MacIntyre DE
1 reference
1 November 1998
1 reference
1 reference
41
1 reference
23
1 reference
4607-4614
1 reference
Identifiers
1 reference
1 reference